JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

HIV

A8554 Dapivirine (TMC120)

Target: Reverse Transcriptases

Summary: Nonnucleoside reverse transcriptase inhibitor

insoluble in H2O; ≥13.5 mg/mL
A8311 Maraviroc
2 Citation

Target: CCR

Summary: Selective CCR5 antagonist,antiretroviral agent

≥25.7 mg/mL
A8206 Darunavir
2 Citation

Summary: HIV-1 protease inhibitor

≥22.65 mg/mL
A8204 Lopinavir

Summary: HIV protease inhibitor,highly potent

≥31.45 mg/mL
A8203 Ritonavir

Summary: HIV protease inhibitor

≥26 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A4074 S/GSK1349572

Summary: HIV integrase inhibitor, novel and potent

≥41.9 mg/mL
A4073 Raltegravir (MK-0518)
1 Citation

Target: integrase

Summary: HIV-1 integrase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
A4071 Fluorouracil (Adrucil)
12 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A4070 Elvitegravir (GS-9137)

Target: HIV Integrases

Summary: HIV-1 integrase inhibitor,potent

insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL